Locations:

Cancer

February 26, 2019/Cancer/Research

Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis

Daratumumab is effective and safe

February 22, 2019/Cancer/Innovations

How We Reduced Time-to-Treatment by A Third

Our process and results

February 21, 2019/Cancer/Blood Cancers

Three Targeted Agents in Development for Molecular Subtypes of Leukemia

Investigators making strides in cancer drug discovery

February 20, 2019/Cancer/News & Insight

Expertise in Rare Cancers and Blood Disorders

From amyloidosis to small cell bladder cancer

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 19, 2019/Cancer

BCG Shortages Affect Bladder Cancer Care Decisions

Study highlights need for mitigation strategies

February 18, 2019/Cancer/Radiation Oncology

Accelerated Partial Breast Irradiation Offers Best Value After Breast-Conserving Surgery

Similar outcomes at lower cost than hypofractionated whole breast irradiation

February 16, 2019/Cancer/Tumor Oncology

KEYNOTE-426: Pembrolizumab + Axitinib or Sunitinib Alone for Advanced Renal Cell Carcinoma?

Combo therapy shows longer OS and PFS and higher ORR

February 15, 2019/Cancer/Tumor Oncology

Short-Term S1505 Results Point to Prospective Radiological Review

Preoperative chemo approach in pancreatic cancer

February 14, 2019/Cancer/Research

Going to the 2019 Genitourinary Cancers Symposium? Make Sure to Attend Our Cleveland Clinic Sessions

Join us at the Genitourinary Cancers Symposium Feb. 14-16

February 13, 2019/Cancer/Blood Cancers

Personalized Survivorship Care Plans Reduce Distress, Improve QOL in HCT Survivors

Plans generated from readily available data

BackPage 64 of 140Next